What's breaking now, across thousands of outlets.
A twice-yearly injection could revolutionise HIV prevention, but who gets access raises bigger questions.
We haven't written up this one. Al Jazeera has the full story — the link below goes straight to it.
(MedPage Today) -- An all-oral treatment regimen for advanced estrogen receptor (ER)-positive breast cancer almost doubled progression-free survival (PFS) versus standard endocrine therapy in a study…
Catch up on the stories we’re following today
State health officials race to vaccinate residents by giving over 8,500 doses.
State health officials race to vaccinate residents by giving over 8,500 doses.
